lysyl-aspartyl-glutamyl-leucine and Adenocarcinoma

lysyl-aspartyl-glutamyl-leucine has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Meijer, J; Roos, E; Sipos, B; Zeelenberg, IS	1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Adenocarcinoma

Article	Year
The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer research, 2006, Oct-01, Volume: 66, Issue:19 Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Chemokine CXCL13; Chemokines, CXC; Colonic Neoplasms; Drug Delivery Systems; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Organ Specificity; Pancreatic Neoplasms; Protein Sorting Signals; Receptors, Chemokine; Receptors, CXCR5; Recombinant Fusion Proteins; Spleen; Splenic Neoplasms; Transfection	2006

Article

Year

The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.

Cancer research, 2006, Oct-01, Volume: 66, Issue:19

Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Chemokine CXCL13; Chemokines, CXC; Colonic Neoplasms; Drug Delivery Systems; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Organ Specificity; Pancreatic Neoplasms; Protein Sorting Signals; Receptors, Chemokine; Receptors, CXCR5; Recombinant Fusion Proteins; Spleen; Splenic Neoplasms; Transfection

2006